Company news

Theravance Biopharma, Inc. news in 2020

Theravance Biopharma, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Theravance Biopharma to Present at the 3rd Annual Evercore ISI HEALTHCONx Conference

November 16, 2020

Theravance Biopharma, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

November 4, 2020

Theravance Biopharma to Report Third Quarter 2020 Financial Results on November 5, 2020

October 21, 2020

Theravance Biopharma, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update

August 5, 2020

Theravance Biopharma to Report Second Quarter 2020 Financial Results on August 6, 2020

July 26, 2020

Theravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of Directors

July 1, 2020

Theravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD-0903 for the Treatment of Hospitalized Patients with Acute Lung Injury Caused by COVID-19

June 24, 2020

Theravance Biopharma, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update

May 5, 2020

Theravance Biopharma to Report First Quarter 2020 Financial Results on May 6, 2020

April 27, 2020

Theravance Biopharma Announces First Subject Dosed in Phase 1 Study of TD-0903, in Development for the Treatment of Hospitalized Patients with Acute Lung Injury Caused by COVID-19

April 22, 2020

Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis

April 19, 2020

Theravance Biopharma Responds to COVID-19 Pandemic by Advancing TD-0903 to Treat Hospitalized Patients with Acute Lung Injury

April 8, 2020

Theravance Biopharma Announces Closing of Private Placement of $400 Million Non-Recourse Notes

March 1, 2020

Theravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update

February 23, 2020

Theravance Biopharma Announces Presentations at Upcoming Investor Conferences

February 17, 2020

Theravance Biopharma to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020

February 12, 2020

Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares

February 10, 2020

Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares

February 9, 2020

Theravance Biopharma Announces Presentation at the 38th Annual J.P. Morgan Healthcare Conference

January 6, 2020

Decks in 2020